Cardax (CDXI) Stock Price, News & Analysis
Company Description
Cardax (OTC Link: CDXI) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $3.2K.
This page collects what Stock Titan holds for CDXI, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Cardax (CDXI) stock last closed at $0.0000. At a market capitalization of $3.2K, CDXI is classified as a micro-cap stock.
Latest News
Cardax has 4 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 1 with negative movement. Key topics include earnings. View all CDXI news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
CDXI Company Profile & Sector Positioning
Cardax (CDXI) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CDXI often look at related companies in the same sector, including Rebus Hldgs Inc (RBSH), Ampio Pharma (AMPE), Oncology Pharma (ONPH), Kaleido Biosciences (KLDO), and BETTER THERAPEUTICS INC (BTTX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CDXI's relative position within its industry.